The epidemiology of irritable bowel syndrome in North America: a systematic review.
about
Placebos without deception: a randomized controlled trial in irritable bowel syndromeCatechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndromeAcupuncture for treatment of irritable bowel syndromeMoxibustion for Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsNew and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologistsDiagnosis and treatment of diarrhea-predominant irritable bowel syndromeAdvances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotideUnraveling the ties between irritable bowel syndrome and intestinal microbiotaOverlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndromeLinaclotide: a new option for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation in adultsElectroacupuncture at He-Mu points reduces P2X4 receptor expression in visceral hypersensitivityLoss-of-Function of the Voltage-Gated Sodium Channel NaV1.5 (Channelopathies) in Patients With Irritable Bowel SyndromeEnergetic stress: The reciprocal relationship between energy availability and the stress response.Responders vs clinical response: a critical analysis of data from linaclotide phase 3 clinical trials in IBS-CComplementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS).Evaluation of serum-derived bovine immunoglobulin protein isolate in subjects with diarrhea-predominant irritable bowel syndrome.Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation.Estimating the burden of irritable bowel syndrome: analysis of a nationwide korean database.Frequency of abnormal fecal biomarkers in irritable bowel syndrome.Pediatric functional gastrointestinal disorders.An Evidence-Based Look at Misconceptions in the Treatment of Patients with IBS-DA cross-sectional study of risk factors for irritable bowel syndrome in children 8-13 years of age in suzhou, china.Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome.Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome.SYMPOSIUM REPORT: An Evidence-Based Approach to IBS and CIC: Applying New Advances to Daily Practice: A Review of an Adjunct Clinical Symposium of the American College of Gastroenterology Meeting October 16, 2016 • Las Vegas, Nevada.Association Between SLC6A4 Serotonin Transporter Gene Lainked Polymorphic Region and ADRA2A -1291C>G and Irritable Bowel Syndrome in KoreaImpact of functional gastrointestinal disorders on survival in the community.Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease.Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome.Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria.Oxytocin decreases colonic motility of cold water stressed rats via oxytocin receptors.Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distressEffect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome.Otilonium bromide in irritable bowel syndrome: a dose-ranging randomized double-blind placebo-controlled trial.Impact of linaclotide treatment on work productivity and activity impairment in adults with irritable bowel syndrome with constipation: results from 2 randomized, double-blind, placebo-controlled phase 3 trials.
P2860
Q21091076-D418F254-0514-4B6B-8DF9-16413D8AFD5CQ21133920-38FDE794-53B7-437B-95C6-F26A7428B1F9Q24197693-74390744-5464-4A58-AE34-551FED5E71E4Q26746961-912D6160-05B5-451F-84B3-111DC4AB0E18Q26748617-EF9B5EAD-99B1-420C-8124-5451CE6C61CFQ26765272-1950BCBA-C830-40AD-A5A6-A293539A0FBFQ26865304-1EF1DFFF-E0DC-48D8-88F3-F01D754CF6B2Q27004645-110318A2-9983-4142-9838-0C0F2D397EF4Q27008998-E695D485-78ED-48A2-A728-324E43114253Q27010449-0FF7E170-7740-472E-A025-7A3C7FD9B449Q28656431-E7B2E504-80A9-455A-8987-9F30CA8C3186Q29544671-A9D517BF-D86D-4774-9E13-021A5E576837Q30252080-2409A8BF-C630-480B-8F15-AD192AB067A6Q30724990-0F515398-54B6-4C90-9440-A2AAEFE253B0Q33354789-8D16BDEF-C895-4DE1-8CF2-CA274C72B614Q33449885-ECD54878-1D71-4629-B601-4E671F698960Q33451900-0AC60282-CDE1-4DC4-97B6-81CA62A4C0D1Q33452388-48362A4A-3070-4185-97C6-31BDF4B6CA60Q33461640-6B2886EE-EE89-43FA-A95A-9A661263A9D3Q33586854-3B735D0C-A4E0-40ED-9B12-E1FE59ED04E6Q33586874-901402EA-570C-4D7E-AA1C-0AED57FA7A97Q33648553-9676CC93-95CA-4587-AD2D-A180898F3E3AQ33651592-29649A99-D0C0-40FB-8F0E-E2D9E9F293C1Q33667183-E80CC32E-E624-40D6-88EB-7255903B9E38Q33668731-5FAB9104-CB9A-4B33-8241-15DC5471BCD1Q33781168-378E12CB-D9C9-4F30-9673-50AEEC480209Q33801285-4FE80273-33CF-4937-BE40-6EA050181658Q33865075-7D4B1836-1CC7-4C93-B94E-D928DECE0837Q33915249-27EC2FB4-50E9-4F91-A3AF-F8521FEBF50FQ33919405-3442FB72-7D13-4F12-AF1E-84C9E086F27FQ33951233-4EB99153-8E3E-4217-88E7-170F9301DFBDQ33958710-45C1E0D9-8C4A-43AD-AFEA-F5B053811D76Q33958801-B3708964-EB24-45BC-8FCA-6C4973470FFDQ33977333-BB253DC5-8B9C-449F-B226-0F1410BBE18DQ34020205-E4B551F7-7AAB-46A5-877E-E4BEF8080930Q34067890-0503762C-7854-48AC-AA35-2944786E9360Q34126831-AE5C7530-0A09-4429-BF79-1EA3F1C8B8B9Q34129435-4A4E5DF1-2343-4D2B-AB32-ABA19C9759E0Q34168626-2DAD42FF-BBCA-461C-96AD-9617BD9DE4F7Q34179472-B2181D47-D410-4B63-8A98-2A4F86ED08AE
P2860
The epidemiology of irritable bowel syndrome in North America: a systematic review.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The epidemiology of irritable bowel syndrome in North America: a systematic review.
@ast
The epidemiology of irritable bowel syndrome in North America: a systematic review.
@en
The epidemiology of irritable bowel syndrome in North America: a systematic review.
@nl
type
label
The epidemiology of irritable bowel syndrome in North America: a systematic review.
@ast
The epidemiology of irritable bowel syndrome in North America: a systematic review.
@en
The epidemiology of irritable bowel syndrome in North America: a systematic review.
@nl
prefLabel
The epidemiology of irritable bowel syndrome in North America: a systematic review.
@ast
The epidemiology of irritable bowel syndrome in North America: a systematic review.
@en
The epidemiology of irritable bowel syndrome in North America: a systematic review.
@nl
P2093
P2860
P1476
The epidemiology of irritable bowel syndrome in North America: a systematic review.
@en
P2093
G Richard Locke
Philip Schoenfeld
Yuri A Saito
P2860
P304
P356
10.1111/J.1572-0241.2002.05913.X
P407
P577
2002-08-01T00:00:00Z